{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:44:36Z","timestamp":1792025076317,"version":"4.4.0"},"reference-count":112,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008108","name":"Taipei Tzu-Chi Hospital, Taiwan","doi-asserted-by":"publisher","award":["TCRD-TPE-113-12"],"award-info":[{"award-number":["TCRD-TPE-113-12"]}],"id":[{"id":"10.13039\/501100008108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is a prevalent metabolic disorder among women of reproductive age, characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. The pathogenesis of PCOS involves a complex interplay of genetic and environmental factors, including insulin resistance (IR) and resultant hyperinsulinemia. Insulin receptors, primarily in skeletal muscle, liver, and adipose tissue, activate downstream signaling pathways like PI3K-AKT and MAPK-ERK upon binding. These pathways regulate glucose uptake, storage, and lipid metabolism. Genome-wide association studies (GWASs) have identified several candidate genes related to steroidogenesis and insulin signaling. Environmental factors such as endocrine-disrupting chemicals and lifestyle choices also exacerbate PCOS traits. Other than lifestyle modification and surgical intervention, management strategies for PCOS can be achieved by using pharmacological treatments like antiandrogens, metformin, thiazolidinediones, aromatase inhibitor, and ovulation drugs to improve insulin sensitivity and ovulatory function, as well as combined oral contraceptives with or without cyproterone to resume menstrual regularity. Despite the complex pathophysiology and significant economic burden of PCOS, a comprehensive understanding of its molecular and cellular mechanisms is crucial for developing effective public health policies and treatment strategies. Nevertheless, many unknown aspects of PCOS, including detailed mechanisms of actions, along with the safety and effectiveness for the treatment, warrant further investigation.<\/jats:p>","DOI":"10.3390\/ijms25169037","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T09:13:48Z","timestamp":1724145228000},"page":"9037","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["The Pathophysiological Mechanism and Clinical Treatment of Polycystic Ovary Syndrome: A Molecular and Cellular Review of the Literature"],"prefix":"10.3390","volume":"25","author":[{"given":"Kai-Jung","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Taipei Tzu-Chi Hospital, The Buddhist Tzu-Chi Medical Foundation, New Taipei City 23142, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Hong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medicine, MacKay Medical College, New Taipei City 25245, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4758-0351","authenticated-orcid":false,"given":"Kuo-Hu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Taipei Tzu-Chi Hospital, The Buddhist Tzu-Chi Medical Foundation, New Taipei City 23142, Taiwan"},{"name":"School of Medicine, Tzu-Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"Clinical Practice. Polycystic Ovary Syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_2","first-page":"336","article-title":"Polycystic Ovary Syndrome: A Review of Treatment Options with a Focus on Pharmacological Approaches","volume":"38","author":"Ndefo","year":"2013","journal-title":"Pharm. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review","volume":"13","author":"Deswal","year":"2020","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Goh, J.E., Farrukh, M.J., Keshavarzi, F., Yap, C.S., Saleem, Z., Salman, A., and John, A. (2022). Assessment of Prevalence, Knowledge of Polycystic Ovary Syndrome and Health-related Practices among Women in Klang Valley: A Cross-sectional Survey. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.985588"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Wolf, W.M., Wattick, R.A., Kinkade, O.N., and Olfert, M.D. (2018). Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race\/Ethnicity. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15112589"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2017.01.003","article-title":"Racial and Ethnic Differences in the Polycystic Ovary Syndrome Metabolic Phenotype","volume":"216","author":"Engmann","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.steroids.2013.04.006","article-title":"Ethnic Differences in the Phenotypic Expression of Polycystic Ovary Syndrome","volume":"78","author":"Zhao","year":"2013","journal-title":"Steroids"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Singh, S., Pal, N., Shubham, S., Sarma, D.K., Verma, V., Marotta, F., and Kumar, M. (2023). Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041454"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.apjtm.2015.07.001","article-title":"Risk Factors of Polycystic Ovarian Syndrome Among Li People","volume":"8","author":"Shan","year":"2015","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Pe\u00f1a, A.S., Codner, E., and Witchel, S. (2022). Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review. Diagnostics, 12.","DOI":"10.3390\/diagnostics12081931"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Christ, J.P., and Cedars, M.I. (2023). Current Guidelines for Diagnosing PCOS. Diagnostics, 13.","DOI":"10.3390\/diagnostics13061113"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment","volume":"14","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/TACG.S200341","article-title":"Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives","volume":"12","author":"Khan","year":"2019","journal-title":"Appl. Clin. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.fertnstert.2016.08.031","article-title":"Polycystic Ovary Syndrome and Environmental Toxins","volume":"106","author":"Rutkowska","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zhang, B., Zhou, W., Shi, Y., Zhang, J., Cui, L., and Chen, Z.J. (2020). Lifestyle and Environmental Contributions to Ovulatory Dysfunction in Women of Polycystic Ovary Syndrome. BMC Endocr. Disord., 20.","DOI":"10.1186\/s12902-020-0497-6"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43042-019-0031-4","article-title":"Hyperandrogenism in Polycystic Ovarian Syndrome and Role of CYP Gene Variants: A Review","volume":"20","author":"Ashraf","year":"2019","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"ref_17","unstructured":"Weiss, M., Steiner, D.F., and Philipson, L.H. (2024, April 21). Insulin Biosynthesis, Secretion, Structure, and Structure-Activity Relationships, Comprehensive Free Online Endocrinology Book, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279029\/."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/clinem\/dgab613","article-title":"Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences","volume":"107","author":"Riestenberg","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"17455057221117966","DOI":"10.1177\/17455057221117966","article-title":"An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options","volume":"18","author":"Islam","year":"2022","journal-title":"Women\u2019s Health (Lond)"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","article-title":"Diagnosis of Polycystic Ovary Syndrome: Which Criteria to Use and When?","volume":"50","author":"Chang","year":"2021","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajum.12096","article-title":"Rotterdam criteria, the end","volume":"21","author":"Smet","year":"2018","journal-title":"Australas. J. Ultrasound Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/ijem.IJEM_30_19","article-title":"Comparison of the Different PCOS Phenotypes Based on Clinical Metabolic, and Hormonal Profile, and their Response to Clomiphene","volume":"23","author":"Sachdeva","year":"2019","journal-title":"Indian. J. Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1177\/1933719114522525","article-title":"Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome","volume":"21","author":"Clark","year":"2014","journal-title":"Reprod. Sci."},{"key":"ref_24","first-page":"17","article-title":"Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH","volume":"18","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil. Steril."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Farhadi-Azar, M., Aminorroaya, A., Heidari-Beni, M., Khamseh, F., Nouri, M., Kazerouni, F., and Amini, M. (2022). The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study. Front. Endocrinol. (Lausanne), 13.","DOI":"10.3389\/fendo.2022.825528"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wawrzkiewicz-Ja\u0142owiecka, A., Kowalczyk, K., Trybek, P., Duleba, A.J., Kurzawa, R., Bednarek, W., Skrzypulec-Plinta, V., Meczekalski, B., and G\u0142owacka, I. (2020). In Search of New Therapeutics-Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197054"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ajmal, N., Khan, S.Z., and Shaikh, R. (2019). Polycystic ovary syndrome (PCOS) and genetic predisposition: A review article. Eur. J. Obstet. Gynecol. Reprod. Biol. X, 3.","DOI":"10.1016\/j.eurox.2019.100060"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hiam, D., Moreno-Asso, A., Teede, H.J., Laven, J.S., Stepto, N.K., and Moran, L.J. (2019). The Genetics of Polycystic Ovary Syndrome: An Overview of Candidate Gene Systematic Reviews and Genome-Wide Association Studies. J. Clin. Med., 8.","DOI":"10.3390\/jcm8101606"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.20945\/2359-3997000000049","article-title":"An update of genetic basis of PCOS pathogenesis","volume":"62","author":"Crespo","year":"2018","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Nautiyal, H., Imam, S.S., Alshehri, S., Ghoneim, M.M., Afzal, M., Alzarea, S.I., G\u00fcven, E., Al-Abbasi, F.A., and Kazmi, I. (2022). Polycystic Ovarian Syndrome: A Complex. Disease with a Genetics Approach. Biomedicines, 10.","DOI":"10.3390\/biomedicines10030540"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.96.15.8573","article-title":"Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin","volume":"96","author":"Urbanek","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/humupd\/7.4.405","article-title":"Candidate genes in polycystic ovary syndrome","volume":"7","author":"Franks","year":"2001","journal-title":"Hum. Reprod. Update"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.4158\/EP-2020-0347","article-title":"Cholesterol Review: A Metabolically Important Molecule","volume":"26","author":"Schade","year":"2020","journal-title":"Endocr. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Shi, Q., Yin, S., Wang, J., Liang, S., and Duan, Z. (2022). Intracellular Cholesterol Synthesis and Transport. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.819281"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41435-021-00139-3","article-title":"Revisiting steroidogenesis and its role in immune regulation with the advanced tools and technologies","volume":"22","author":"Chakraborty","year":"2021","journal-title":"Genes. Immun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1210\/me.2004-0532","article-title":"Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: More complicated than we thought","volume":"19","author":"Stocco","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2470547018818555","DOI":"10.1177\/2470547018818555","article-title":"Overview of the Molecular Steps in Steroidogenesis of the GABAergic Neurosteroids Allopregnanolone and Pregnanolone","volume":"2","author":"Liang","year":"2018","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/6.3.397","article-title":"Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism","volume":"6","author":"Gharani","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/09513590.2020.1770724","article-title":"CYP17 gene polymorphic sequence variation is associated with hyperandrogenism in Kashmiri women with polycystic ovarian syndrome","volume":"37","author":"Ashraf","year":"2021","journal-title":"Gynecol. Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"100996","DOI":"10.1016\/j.mgene.2021.100996","article-title":"Association of CYP17 gene polymorphism (rs743572) with polycystic ovary syndrome","volume":"31","author":"Ali","year":"2022","journal-title":"Meta Gene"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/er.2003-0030","article-title":"Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones","volume":"25","author":"Payne","year":"2004","journal-title":"Endocr. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Ashraf, S., Rasool, S.U.A., Nabi, M., Ganie, M.A., Masoodi, S.R., and Amin, S. (2021). Impact of rs2414096 Polymorphism of CYP19 Gene on Susceptibility of Polycystic Ovary Syndrome and Hyperandrogenism in Kashmiri Women. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-92265-1"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/deh900","article-title":"Association of Aromatase (CYP 19) Gene Variation with Features of Hyperandrogenism in Two Populations of Young Women","volume":"20","author":"Petry","year":"2005","journal-title":"Hum. Reprod."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.fertnstert.2009.01.147","article-title":"CYP19 Gene: A Genetic Modifier of Polycystic Ovary Syndrome Phenotype","volume":"94","author":"Xita","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_49","first-page":"1315","article-title":"The Role of Heterozygosity for CYP21 in the Polycystic Ovary Syndrome","volume":"13","author":"Witchel","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fertnstert.2004.10.027","article-title":"Prevalence of CYP21 Mutations and IRS1 Variant among Women with Polycystic Ovary Syndrome and Adrenal Androgen Excess","volume":"83","author":"Witchel","year":"2005","journal-title":"Fertil. Steril."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"101255","DOI":"10.1016\/j.molmet.2021.101255","article-title":"Understanding Insulin and Its Receptor from Their Three-Dimensional Structures","volume":"52","author":"Lawrence","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/bmc-2014-0005","article-title":"The Structure, Molecular Interactions and Bioactivities of Proinsulin C-Peptide Correlate with a Tripartite Molecule","volume":"5","author":"Landreh","year":"2014","journal-title":"Biomol. Concepts"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0026-0495(77)90099-3","article-title":"Proinsulin and C-Peptide: A Review","volume":"26","author":"Kitabchi","year":"1977","journal-title":"Metabolism"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s13300-017-0265-4","article-title":"A Practical Review of C-Peptide Testing in Diabetes","volume":"8","author":"Leighton","year":"2017","journal-title":"Diabetes Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of Insulin Action and Insulin Resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_56","unstructured":"De Meyts, P. (2024, May 20). The Insulin Receptor and Its Signal Transduction Network, Comprehensive Free Online Endocrinology Book, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK378978\/."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"101304","DOI":"10.1016\/j.molmet.2021.101304","article-title":"Insulin Action at a Molecular Level\u2014100 Years of Progress","volume":"52","author":"White","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/cphy.c190029","article-title":"Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake","volume":"10","author":"Merz","year":"2020","journal-title":"Compr. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cmet.2021.03.020","article-title":"The Many Actions of Insulin in Skeletal Muscle, the Paramount Tissue Determining Glycemia","volume":"33","author":"Sylow","year":"2021","journal-title":"Cell Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI27073","article-title":"Insulin\u2019s Direct Effects on the Liver Dominate the Control of Hepatic Glucose Production","volume":"116","author":"Edgerton","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.coph.2020.10.016","article-title":"The Role of the Liver in the Modulation of Glucose and Insulin in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes","volume":"55","author":"Guerra","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tem.2017.03.003","article-title":"Unraveling the Regulation of Hepatic Metabolism by Insulin","volume":"28","author":"Titchenell","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cmet.2021.03.019","article-title":"Insulin Action in Adipocytes, Adipose Remodeling, and Systemic Effects","volume":"33","author":"Santoro","year":"2021","journal-title":"Cell Metab."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S0168-8227(11)70014-6","article-title":"Insulin Effects in Muscle and Adipose Tissue","volume":"93","author":"Dimitriadis","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11886-016-0755-4","article-title":"Genetics of Insulin Resistance and the Metabolic Syndrome","volume":"18","author":"Brown","year":"2016","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Parikh, H.M., Chan, Y.Y., Lin, S.J., Liao, C.W., Wu, C.S., Chen, C.J., and Chen, Y.T. (2021). Relationship Between Insulin Sensitivity and Gene Expression in Human Skeletal Muscle. BMC Endocr. Disord., 21.","DOI":"10.1186\/s12902-021-00687-9"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCRESAHA.119.315246","article-title":"Functional Screening of Candidate Causal Genes for Insulin Resistance in Human Preadipocytes and Adipocytes","volume":"126","author":"Chen","year":"2020","journal-title":"Circ. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","article-title":"Genetic Syndromes of Severe Insulin Resistance","volume":"32","author":"Semple","year":"2011","journal-title":"Endocr. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Harada, M. (2022). Pathophysiology of Polycystic Ovary Syndrome Revisited: Current Understanding and Perspectives Regarding Future Research. Reprod. Med. Biol., 21.","DOI":"10.1002\/rmb2.12487"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bpobgyn.2004.05.004","article-title":"The Pathophysiology of Polycystic Ovary Syndrome: Trying to Understand PCOS and Its Endocrinology","volume":"18","author":"Balen","year":"2004","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Jozkowiak, M., Imakawa, K., and Takahashi, T. (2022). Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction. Cells, 12.","DOI":"10.3390\/cells12010174"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0000000000000563","article-title":"Clinical Presentation and Diagnosis of Polycystic Ovarian Syndrome","volume":"64","author":"Lentscher","year":"2021","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Sidra, S., Tariq, M.H., Farrukh, M.J., and Mohsin, M. (2019). Evaluation of Clinical Manifestations, Health Risks, and Quality of Life Among Women with Polycystic Ovary Syndrome. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223329"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Ranathunga, I., Rameez, M.F., Ranasinghe, P., and Katulanda, P. (2022). Evaluation of Socio-Demographic and Clinical Characteristics of PCOS Patients Attending a Tertiary Care Institute in Colombo. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-01206-0"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4158\/EP12235.OR","article-title":"Polycystic Ovary Syndrome: Clinical Presentation in Normal-Weight Compared with Overweight Adolescents","volume":"19","author":"McManus","year":"2013","journal-title":"Endocr. Pract."},{"key":"ref_77","first-page":"Cd007506","article-title":"Lifestyle Changes in Women with Polycystic Ovary Syndrome","volume":"3","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000519302","article-title":"Dietary Interventions: A Promising Treatment for Polycystic Ovary Syndrome","volume":"77","author":"Che","year":"2021","journal-title":"Ann. Nutr. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Szczuko, M., Skowronek, M., Zi\u0119tek, M., Kikut, J., Czerwi\u0144ska, E., Maciejewska, D., and Komorniak, N. (2021). Nutrition Strategy and Life Style in Polycystic Ovary Syndrome-Narrative Review. Nutrients, 13.","DOI":"10.3390\/nu13072452"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Cowan, S., Ogutu, S., and Small, C. (2023). Lifestyle Management in Polycystic Ovary Syndrome\u2014Beyond Diet and Physical Activity. BMC Endocr. Disord., 23.","DOI":"10.1186\/s12902-022-01208-y"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tjog.2021.11.009","article-title":"Polycystic Ovarian Syndrome-Current Pharmacotherapy and Clinical Implications","volume":"61","author":"Rashid","year":"2022","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"ref_82","first-page":"671","article-title":"Drug Treatments for Polycystic Ovary Syndrome","volume":"79","author":"Radosh","year":"2009","journal-title":"Am. Fam. Physician"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic Ovary Syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Lv, Z., and Guo, Y. (2020). Metformin and Its Benefits for Various Diseases. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00191"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The Mechanisms of Action of Metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"ref_86","first-page":"e44493","article-title":"Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility","volume":"15","author":"Attia","year":"2023","journal-title":"Cureus"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1089\/dia.2004.6.850","article-title":"Thiazolidinediones: A Review of Their Mechanisms of Insulin Sensitization, Therapeutic Potential, Clinical Efficacy, and Tolerability","volume":"6","author":"Vasudevan","year":"2004","journal-title":"Diabetes Technol. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/VHRM.S993","article-title":"Peroxisome Proliferator-Activated Receptor-Gamma Agonists and Diabetes: Current Evidence and Future Perspectives","volume":"4","author":"Chiarelli","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"73986","DOI":"10.1155\/PPAR\/2006\/73986","article-title":"Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)","volume":"2006","author":"Froment","year":"2006","journal-title":"PPAR Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12978-021-01207-7","article-title":"Comparative Efficacy of Oral Insulin Sensitizers Metformin, Thiazolidinediones, Inositol, and Berberine in Improving Endocrine and Metabolic Profiles in Women with PCOS: A Network Meta-Analysis","volume":"18","author":"Zhao","year":"2021","journal-title":"Reprod. Health"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.steroids.2011.11.014","article-title":"The Role of Heterozygosity for CYP21 PCOS","volume":"77","author":"Duleba","year":"2012","journal-title":"Steroids"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2042018820938305","DOI":"10.1177\/2042018820938305","article-title":"A Review of Therapeutic Options for Managing the Metabolic Aspects of Polycystic Ovary Syndrome","volume":"11","author":"Abdalla","year":"2020","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Cunha, A., and P\u00f3voa, A.M. (2021). Infertility Management in Women with Polycystic Ovary Syndrome: A Review. Porto Biomed. J., 6.","DOI":"10.1097\/j.pbj.0000000000000116"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/humupd\/2.6.483","article-title":"Development, Pharmacology and Clinical Experience with Clomiphene Citrate","volume":"2","author":"Dickey","year":"1996","journal-title":"Hum. Reprod. Update"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The Management of Anovulatory Infertility in Women with Polycystic Ovary Syndrome: An Analysis of the Evidence to Support the Development of Global WHO Guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0960-0760(03)00384-4","article-title":"The Pharmacology of Letrozole","volume":"87","author":"Haynes","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"121074","DOI":"10.1016\/j.lfs.2022.121074","article-title":"Letrozole: Pharmacology, Toxicity and Potential Therapeutic Effects","volume":"310","author":"Mukherjee","year":"2022","journal-title":"Life Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/AOG.0000000000005070","article-title":"Letrozole Compared with Clomiphene Citrate for Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis","volume":"141","author":"Liu","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s42000-021-00289-z","article-title":"Higher Ovulation Rate with Letrozole as Compared with Clomiphene Citrate in Infertile Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis","volume":"20","author":"Tsiami","year":"2021","journal-title":"Hormones (Athens)"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.mefs.2010.10.003","article-title":"The Role of Metformin in Ovulation Induction: Current Status","volume":"16","author":"Elnashar","year":"2011","journal-title":"Middle East. Fertil. Soc. J."},{"key":"ref_101","first-page":"56","article-title":"Metformin Use in Women with Polycystic Ovary Syndrome","volume":"2","author":"Johnson","year":"2014","journal-title":"Ann. Transl. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2021.21392","article-title":"Contraception Selection, Effectiveness, and Adverse Effects: A Review","volume":"326","author":"Teal","year":"2021","journal-title":"JAMA"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejendo\/lvad082","article-title":"Different Kinds of Oral Contraceptive Pills in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis","volume":"189","author":"Forslund","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/OAJC.S85543","article-title":"Hormonal Contraception in Women with Polycystic Ovary Syndrome: Choices, Challenges, and Noncontraceptive Benefits","volume":"8","author":"Dias","year":"2017","journal-title":"Open Access J. Contracept."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1472-6483(10)62107-4","article-title":"Surgical Treatment of Polycystic Ovary Syndrome Associated with Infertility","volume":"9","author":"Gomel","year":"2004","journal-title":"Reprod. Biomed. Online"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Della Corte, L., Barra, F., Farthing, A., Bifulco, G., Di Martino, G., Ferrero, S., and Giampaolino, P. (2023). Is There Still a Place for Surgery in Patients with PCOS? A Review. Life, 13.","DOI":"10.3390\/life13061270"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0377-1237(06)80051-1","article-title":"Surgical Approach for Polycystic Ovarian Syndrome in Management of Infertility","volume":"62","author":"Rath","year":"2006","journal-title":"Med. J. Armed Forces India"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"155745","DOI":"10.1016\/j.metabol.2023.155745","article-title":"Bariatric Surgery in Women with Polycystic Ovary Syndrome","volume":"151","author":"Samarasinghe","year":"2024","journal-title":"Metabolism"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1007\/s11695-022-06209-3","article-title":"Effects of Bariatric Surgery on People with Obesity and Polycystic Ovary Syndrome: A Large Single Center Study from India","volume":"32","author":"Bhandari","year":"2022","journal-title":"Obes. Surg."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bjps.2006.11.006","article-title":"Laser hair removal in women with polycystic ovary syndrome","volume":"60","author":"McGill","year":"2007","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"ref_111","first-page":"3","article-title":"Electrolysis for the treatment of hypertrichosis and hirsutism","volume":"4","author":"Richards","year":"1999","journal-title":"Skin. Ther. Lett."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Xue, Z., Feng, Y., Lin, X., and Qiao, J. (2021). Research Progress on the Mechanism Between Polycystic Ovary Syndrome and Abnormal Endometrium. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.788772"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/9037\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:39:47Z","timestamp":1760110787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/9037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":112,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ijms25169037"],"URL":"https:\/\/doi.org\/10.3390\/ijms25169037","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]}}}